Glembatumumab vedotin is a novel method in tumor treatment. This ADC selectively recognizes a molecule expressed on various tumor cells, transporting an potent anti-cancer drug. Early medical trials demonstrate https://www.targetmol.com/compound/glembatumumab_vedotin